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In hepatocytes ethanol (EtOH) is metabolized to acetaldehyde and to acetate. Ursodeoxycholic acid (UDCA) and tauroursodeoxycholic
acid (TUDCA) are said to protect the liver against alcohol. We investigated the influence of ethanol and acetaldehyde on alcohol
dehydrogenase (ADH)-containing human hepatoma cells (SK-Hep-1) and the protective effects of UDCA and TUDCA (0.01 and 0.1 mM).
Cells were incubated with 100 and 200 mM ethanol, concentrations in a heavy drinker, or acetaldehyde. Treatment with acetaldehyde or
ethanol resulted in a decrease of metabolic activity and viability of hepatocytes and an increase of cell membrane permeability. During
simultaneous incubation with bile acids, the metabolic activity was better preserved by UDCA than by TUDCA. Due to its more polar
character, acetaldehyde mostly damaged the superficial, more polar domain of the membrane. TUDCA reduced this effect, UDCA was less
effective. Damage caused by ethanol was smaller and predominantly at the more apolar site of the cell membrane. In contrast, preincubation
with TUDCA or UDCA strongly decreased metabolic activity and cell viability and led to an appreciable increase of membrane permeability.
TUDCA and UDCA only in rather high concentrations reduce ethanol and acetaldehyde-induced toxicity in a different way, when incubated
simultaneously with hepatocytes. In contrast, preincubation with bile acids intensified cell damage. Therefore, the protective effect of UDCA
or TUDCA in alcohol- or acetaldehyde-treated SK-Hep-1 cells remains dubious.
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1. Introduction (MEOS: CYP2E1) and catalase in both peroxisomes andThe liver is the main site of ethanol metabolism and
offers three metabolic pathways: the cytosolic enzymes
alcohol dehydrogenase (ADH) and aldehyde dehydroge-
nase (AlDH), the microsomal ethanol oxidizing system0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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Abbreviations: ADH, alcohol dehydrogenase; AlDH, acetaldehyde
dehydrogenase; ASH, alcoholic steatohepatitis; CDCA, cheno 3a,7h-
dihydroxy-5h-cholan-24-oic acid; 5-DSA, 5-doxylstearic acid; 16-DSA,
16-doxylstearic acid; EPR, electron paramagnetic resonance spectroscopy;
EtOH, ethanol; G, Gauss; GSH, glutathione; GUDCA, glyco-urso 3a,7h-
dihydroxy-5h-cholan-24-oic acid; LDH, lactate dehydrogenase; MEOS,
microsomal ethanol oxidizing system; a-MEM, a-minimal essential
medium; NASH, nonalcoholic steatohepatitis; TUDCA, tauro-urso 3a,7h-
dihydroxy-5h-cholan-24-oic acid; UDCA, urso 3a,7h-dihydroxy-5h-chol-
an-24-oic acid; WST-1, (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetra-
zolio]-1,3-benzene disulfonate
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Bile acids like chenodeoxycholic acid (CDCA), urso-
deoxycholic acid (UDCA), glycoursodeoxycholic acid
(GUDCA) or tauroursodeoxycholic acid (TUDCA) influ-
ence hepatocyte membrane structure and function [1,2].
Investigations with electron paramagnetic resonance spec-
troscopy (EPR) and experiments on enthalpy and entropy
using differential scanning calorimetry revealed that the
localization of the steroid nucleus of UDCA in the apolar
core and of TUDCA and GUDCA in the interface region of
erythrocyte and hepatocyte membranes near to the phos-
pholipid head groups, like cholesterol stabilizes and protects
membranes against toxic and more apolar bile acids [1,3].
Recent investigations with the isolated perfused rat liver
model revealed that TUDCA also incorporates the bile salt
export pump (Bsep) and the multidrug-resistant protein 2
(Mrp2) into intact hepatocyte membranes [4]. Others have
shown UDCA, TUDCA and GUDCA to protect hepatocytes
against apoptosis induced by ethanol, transforming growth
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These findings suggest that UDCA and TUDCA not only
prevail membrane structure but also function and cell
survival. Since ethanol and acetaldehyde influence both
phospholipid composition and fluidity of the bilayer mem-
brane [9] and cell metabolism, UDCA and TUDCA could
also have protective effects on ethanol-induced hepatocyte
damage. Consequently, UDCA has been recommended for
the treatment of alcohol steatohepatitis (ASH).
The aim of this study was to investigate the effects of the
more hydrophilic bile acids UDCA and TUDCA on acute
ethanol and acetaldehyde alterations in hepatocytes. HepG2
cells have served as a good model for studying hepatotox-
icity of chemicals and drugs, but have the disadvantage that
they have lost most of their ability to express ethanol-
metabolizing enzymes as ADH [10] and cytochrome
P4502E1 [11]. The hepatic carcinoma cell line SK-Hep-1
is of human origin and expresses a manifold higher ADH
activity than previously used HepG2 cells but no AlDH.
Therefore, SK-Hep-1 cells are a suitable model system to
elucidate alcohol hepatotoxicity.2. Materials and methods
Culture media, antibiotics, phosphate-buffered saline
(PBS), trypsin and fetal bovine serum were purchased from
Gibco/BRL (Karlsruhe, Germany). Ethanol (EtOH) was
from Merck (Darmstadt, Germany) and acetaldehyde was
obtained from Sigma (Munich, Germany) and maintained as
1 M stock solution. The sodium salts of UDCA (purity
>99%) and TUDCA (purity >97%) were obtained from
Calbiochem (La Jolla, CA) and maintained as 100 mM
stock solutions. The spin labels 5-doxylstearic acid (5-DSA)
and 16-doxylstearic acid (16-DSA) as well as the ADH-
inhibitor 4-methylpyrazole were purchased from Sigma.
2.1. Experiments
Cell cultures were incubated with EtOH (100 and 200
mM; physiological blood concentration of a heavy drinker)
or acetaldehyde (1.5 and 2.5 mM) together with UDCA or
TUDCA. Since preceding investigations have shown that
low physiological concentrations had no effect on the
hepatocytes and high doses are toxic, concentrations of
0.01 and 0.1 mM were used. Incubation time was 24 h.
Dose dependency of ethanol and acetaldehyde toxicity
were investigated with the WST-1 test in the range of
20–200 mM and 0.5–10 mM, respectively. Hepatocyte
membrane structure was assessed measuring membrane
order, polarity and leakage of lactate dehydrogenase
(LDH) as well as glutathione (GSH) depletion of cells.
GSH also informs on the metabolic state of mitochondria.
The integrity of the inner mitochondrial membrane was
investigated with the WST-1 test to assess metabolic
function. Trypan blue exclusion was measured to ascertaincell viability, cell morphology was investigated microscop-
ically. To find out whether EtOH, when not being metab-
olized to acetaldehyde, is toxic and whether toxicity can be
prevented by bile acids oxidation of EtOH by ADH and
liver microsomal (MEOS) CYP-2E1 was inhibited by
means of 2 AM 4-methylpyrazole. In a second series of
experiments, cells were preincubated for 1 and 4 h with
UDCA or TUDCA (0.01 and/or 0.1 mM each) followed by
EtOH or acetaldehyde.
2.2. Cell culture
SK-Hep-1 cells were obtained from ‘‘Deutsche Samm-
lung von Mikroorganismen und Zellkulturen GmbH’’
(DMSZ, Braunschweig, Germany). Stock cultures in 175
cm2 Falcon culture flasks were maintained in a humidified
CO2-incubator at 37 jC. The cell line was fed with a-
minimal essential medium (a-MEM medium), supple-
mented with heat-inactivated fetal bovine serum (10%, v/
v), 100 U/ml penicillin and 10 Ag/ml streptomycin. Cells
were seeded in Petri dishes and microplates at 5 104/cm2
and examined microscopically (Leica DM-IL; Zeiss, Wet-
zlar, Germany). The cell count was monitored with a
‘‘Neubauer’’ haemacytometer (Fisher Scientific, Nidderau,
Germany).
The media were replaced by serum-free a-MEM medium
containing ethanol (100 and 200 mM) and acetaldehyde (1.5
and 2.5 mM), respectively. Media were supplemented with
0.01 and/or 0.1 mM UDCA or TUDCA. Thereafter, cells
were grown for 24 h and harvested by scraping or trypsi-
nization. Control cells were grown for 24 h in the plain a-
MEM. For preincubation experiments, cells were grown for
1 and 4 h in bile acid (0.01 and/or 0.1 mM) containing a-
MEM medium followed by ethanol or acetaldehyde for
additional 24 h.
2.3. Biochemical studies
2.3.1. Metabolic activity
The WST-1 (Boehringer, Mannheim, Germany) reduc-
tion assay is commonly used as an index of reductive
capacity of electron carriers to evaluate integrity of the
inner mitochondrial membrane. The amount of the highly
water-soluble yellow/red formazan dye generated by dehy-
drogenases in cells is directly proportional to the number of
viable cells. Cells were seeded in 96-well microplates and
grown for 24 h in plain a-MEM and for an additional 24 h in
modified media which contained UDCA or TUDCA (0.01
and 0.1 mM each) and EtOH (100 and 200 mM) or
acetaldehyde (1.5 and 2.5 mM). Afterwards, 20 Al of
WST-1 solution was added to each well and the cells were
allowed to metabolize for 2 h at 37 jC in the incubator.
Optical density was measured at two wavelength modes
(540 and 690 nm) using a microtiter plate spectrophotom-
eter (Rainbow). All values are calculated as the percentage
of the nontoxic control (100%).
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Total GSH levels were measured with a GSH-test-kit
(Calbiochem). For this colorimetric assay, 300 Al cell
culture supernatant was diluted with 600 Al phosphate
buffer (200 mM potassium phosphate, pH 7.8 (25 jC),
containing 0.2 mM diethylene-triamine-pentaacetic acid
(DTPA) and 0.025% LUBROL). After adding 50 Al of a
chromogenic reagent R1, the samples were incubated for 10
min at 25 jC in the dark. Absorbance was measured at 400
nm and GSH concentration was calculated from a GSH
standard curve.
2.3.3. Cell viability
Cell viability was measured as the ability of living cells
to exclude trypan blue vital dye. Cells were trypsinized from
the culture dishes, combined with any floating cells present
in the media, and pelleted by centrifugation at 300 g for
10 min at 4 jC. Cells were washed twice with PBS, pH
7.2–7.4, and trypan blue was added at 0.2% final concen-
tration. Living cells were counted in a haemacytometer and
calculated as the percentage of the total count.
2.3.4. Lactate dehydrogenase leakage
Plasma membrane integrity was assessed using the
cytotoxicity-detection-kit-LDH from Boehringer. Cells were
grown for 24 h in plain a-MEM. The medium was ex-
changed by a modified medium containing bile acids
(UDCA or TUDCA, 0.1 mM each) with or without EtOH
or acetaldehyde and incubated for another 24 h. Supernatant
(100 Al) was transferred into a 96-well microplate, 100
Al substrate was added and after 15 min, incubation reaction
was stopped by adding 50 Al 1 M hydrochloric acid. The
optical density was measured at two wavelength modes (492
and 690 nm) using a microtiter plate spectrophotometer
(Rainbow). LDH release was calculated as the percentage
cytotoxicity according to the instructions.
For determination of protein concentrations, a modifica-
tion of Lowry’s method was used (Sigma).
2.4. EPR spectroscopy
Changes in membrane order (fluidity) and polarity were
monitored by EPR. As paramagnetic reporter groups, we
used the spin label 5-DSA and 16-DSA. These fatty acid
spin labels become incorporated into the plasma membrane
lipid bilayer. 16-DSA reports on the deeper apolar and 5-
DSA on the superficial polar (interface) membrane regions.
Order parameter s and the correction factor c were calcu-
lated according to Gaffney and Lin [12]. S informs on
membrane fluidity and rigidity. Order parameter s = 0 results
from unhindered motion, whereas s= 1 shows ‘‘rigid glass
spectra’’ or membrane inflexibility [13]. The distances AII
and A? were measured in the spectra and the order param-
eter s was calculated. Polarity can be estimated by measur-
ing aN values [1]. In addition to aN, the ratio h 1P/h 1H is a
sensitive parameter of the relative amount of spin label
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calculated from the spectra.
2.4.1. EPR investigations with intact hepatocytes
Cells were seeded in Petri dishes and grown for 24 h in
plain a-MEM. The medium was exchanged by media con-
taining UDCA or TUDCA (each 0.1 mM) with or without
EtOH or acetaldehyde and incubated for another 24 h. After
harvesting, cells were adjusted to 2 107cells/ml PBS. For
each experiment, 50 Al cell suspension was labeled with 5
mM 5-DSA or 5 mM 16-DSA to a final concentration of 0.1
mM 5-DSA or 0.1 mM 16-DSA and incubated for 120 s at
room temperature. Samples were inserted into a Bruker B-R
70 X-band spectrometer with a B-E 25 magnet and spectra of
5-DSA and 16-DSAwere performed at room temperature (25
jC). For computer evaluation of EPR spectra, the Bruker
WIN-EPR program was used.
2.5. Statistics
At least three tests were performed in each experiment.
All data are expressed as meansF S.D. The statistical
significance of the data was assessed by two-tailed Student’s
t-test. A difference at PV 0.05 was considered statistically
significant.3. Results
3.1. ADH-concentrations in SK-Hep-1 cells
ADH activity in the SK-Hep-1 cells was found to be 48
mU/mg protein and was 17.8 times higher than in HepG2-
cells, where it was 2.7 mU/mg protein. SK-Hep-cells did not
express AlDH.
3.2. Biochemical studies
All biochemical methods used revealed no change when
cells were incubated with UDCA or TUDCA alone com-
pared to cells grown in plain a-MEM medium. The same
results were obtained when oxidation of the added EtOH
was inhibited by 4-methylpyrazole. Even the high dose of
100 AM UDCA or TUDCA did not inhibit ADH activity.
3.2.1. Metabolic activity (WST-1 test)
Metabolic activity of SK-Hep-1 cells after 24 h incubation
with a-MEM medium was set to 100% and was used as
control (Table 1). Investigation of the dose dependency of the
toxic effect of acetaldehyde showed at concentrations of 0.5,
1.5, 2.5, 5 and 10 mM significantly decreasing metabolic
activities (versus control, all P < 0.002) from 88.5F 2.1%,
61.4F 2.7%, 50.1F 4.5%, 31.2F 7.1% to 13.3F 6.3%.
Concentrations below 60 mM EtOH did not modify cell
viability, whereas 60, 80, 100, 150 and 200 mM EtOH
decreased metabolic activity to 93.7F 3.1%, 92.1F1.2%
Table 2
GSH release (Amol/mg protein) after 24 h simultaneous incubation of SK-
Hep-1 cells with bile acids and acetaldehyde and 1 and 4 h preincubation
with bile acids followed by 24 h simultaneous incubation with ethanol or
acetaldehyde
Acetaldehyde
(1.5 mM)
Acetaldehyde
(2.5 mM)
EtOH
(100 mM)
EtOH
(200 mM)
a-MEM
Simultaneous
incubation
1.00F 0.12 1.14F 0.02## 0.85F 0.6 0.85F 0.04
0.1 mM UDCA
Simultaneous
incubation
0.86F 0.05 1.05F 0.07* 0.77F 0.02# 0.88F 0.08
1 h pre-
incubation
1.04F 0.16 1.65F 0.15**,## 0.83F 0.10 0.86F 0.02
4 h pre-
incubation
1.00F 0.15 1.27F 0.38 0.80F 0.04 0.90F 0.01
0.1 mM TUDCA
Simultaneous
incubation
1.06F 0.11* 0.93F 0.05* 0.84F 0.07 0.87F 0.07
1 h pre-
incubation
1.19F 0.02*,### 1.42F 0.14*,## 0.84F 0.08 0.89F 0.08
4 h pre-
incubation
1.02F 0.13 1.48F 0.10**,## 0.80F 0.08 0.92F 0.07
Cells, grown in plain a-MEM medium were used as control and showed a
GSH release of 0.83F 0.02 Amol/mg protein (means of three independent
measurementsF S.D.). Statistical significance was calculated versus
control (#P < 0.05; ##P < 0.01; ###P< 0.002) as well as versus ethanol and
acetaldehyde.(*P < 0.05; **P< 0.01).
Table 1
Metabolic activity (%) of SK-Hep-1 cells after 24 h simultaneous
incubation with bile acids and ethanol or acetaldehyde and after 1 and 4
h preincubation with bile acids followed by 24 h simultaneous incubation
with ethanol or acetaldehyde
Acetaldehyde
(1.5 mM)
Acetaldehyde
(2.5 mM)
EtOH
(100 mM)
a-MEM
Simultaneous
incubation
61.4F 2.7 50.1F 4.5 89.2F 2.1
0.01 mM UDCA
Simultaneous
incubation
71.7F 3.5** 57.3F 5.1* 89.6F 2.2
1 h preincubation 39.4F 2.6*** 38.3F 3.4*** 89.1F 2.0
4 h preincubation 33.5F 3.3*** 32.3F 6.1*** 65.2F 5.6***
0.1 mM UDCA
Simultaneous
incubation
75.8F 9.3* 62.0F 8.1 94.9F 2.4*
1 h preincubation 34.4F 4.9*** 35.9F 4.2*** 68.6F 7.1***
4 h preincubation 34.1F 6.2*** 31.2F 4.5*** 60.3F 6.8***
0.01 mM TUDCA
Simultaneous
incubation
68.3F 3.8 66.1F 4.1* 91.3F 2.0
1 h preincubation 40.0F 3.9*** 31.5F 2.8*** 82.0F 11.0
4 h preincubation 35.3F 3.5*** 36.5F 3.5*** 62.7F 4.6**
0.1 mM TUDCA
Simultaneous
incubation
72.5F 4.3* 70.9F 4.2** 91.5F 4.6
1 h preincubation 42.8F 7.1*** 35.1F 7.4*** 79.8F 7.8*
4 h preincubation 37.9F 6.1*** 37.0F 3.4*** 63.9F 9.4***
Statistical significance was calculated versus acetaldehyde and ethanol,
respectively. *P < 0.05; **P < 0.01; ***P < 0.002. Metabolic activity in a-
MEM medium was set to 100%. Values are means of four to six
independent measurementsF S.D.
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and 64.8F 5.8% (P < 0.01). Addition of 1.5 mM acetalde-
hyde decreased metabolic activity to 61.4% (versus control
P < 0.002), whereas simultaneous incubation of 1.5 mM
acetaldehyde with 0.1 mM UDCAyielded a decrease to only
75.8%. UDCA improved the situation by 14.4% (P < 0.05).
When 0.1 mM TUDCA was used metabolic activity de-
creased to 72.5%, which was a significant (P < 0.05) but
only 11.1% improvement compared to acetaldehyde. UDCA
or TUDCA (0.05 mM) reduced toxicity of 1.5 and 2.5 mM
acetaldehyde to 71.4F 3.7% and 61.0F 8.4% or to
71.7F 3.3% and 70.0F 3.0% (all P < 0.05). Also, 0.01
mM UDCA or TUDCA reduced toxicity of 1.5 mM acetal-
dehyde: 0.01 mM UDCA by 10.3% (P < 0.01) and TUDCA
by 6.9% (n.s.). Even the toxic effect of 2.5 mM acetaldehyde
was reduced by bile acids. TUDCA had a better effect than
UDCA. 100mM ethanol did not reveal significant damage on
mitochondrial reductive capacity, however, 0.1 mM UDCA
improved the metabolic activity by 5.7% (P < 0.05), while
0.1 mM TUDCA in the ethanol experiments had no effect.
EtOH did not alter metabolic activity (98.7F 2.8% at 100
mM) when ADH and CYP-2E1 was inhibited by 4-methyl-pyrazole. Preincubation for 1 and 4 h with 0.01 or 0.1 mM
bile acids drastically decreased the metabolic activity of 1.5
and 2.5 mM acetaldehyde by about more than 20%
(P < 0.002; Table 1).
3.2.2. Glutathione release
GSH release of cells after 24 h incubation with a-
MEM medium was 0.83F 0.02 Amol/mg protein and was
used as control. At 1.5 mM acetaldehyde, there was a
slight but not significant increase of GSH in the super-
natant (Table 2), 2.5 mM caused a GSH increase to 1.14
Amol/mg protein (versus control P < 0.01). UDCA and
TUDCA (0.1 mM) reduced this effect (P < 0.05). EtOH
only slightly increased GSH content in the supernatant.
Preincubation of hepatocytes for 1 h with 0.1 mM bile
acids increased the GSH release and intensified the
toxicity of acetaldehyde and only slightly changed the
effects of ethanol. The inhibition of the alcohol-metabo-
lizing enzymes by 4-MPA had no influence.
3.2.3. Cell viability (trypan blue exclusion test)
Another parameter of plasma membrane integrity, but
commonly used as an index of cell viability is the ability of
living cells to exclude trypan blue. Living cells were
counted and calculated as a percentage of the total count.
In the presence of 1.5 mM acetaldehyde viability decreased
to 68.8%, with 2.5 mM acetaldehyde to 42.1%. The high
concentration of 200 mM EtOH induced a decrease to only
Table 4
LDH release (% cytotoxicity) after 24 h simultaneous incubation of SK-
Hep-1 cells with bile acids and ethanol or acetaldehyde and after
preincubation with bile acids for 1 and 4 h followed by 24 h simultaneous
incubation with ethanol or acetaldehyde
Acetaldehyde
(1.5 mM)
Acetaldehyde
(2.5 mM)
EtOH
(100 mM)
EtOH
(200 mM)
a-MEM
Simultaneous
incubation
4.66F 0.93 10.02F 4.01 1.38F 0.07 9.84F 2.46
0.1 mM UDCA
Simultaneous
incubation
0F 0.20 4.15F 1.04 0F 0.01 3.8F 0.68
1 h pre-
incubation
4.32F 0.94 16.93F 15.74 3.45F 0.55 14.85F 10.99
4 h pre-
incubation
6.22F 3.10 32.64F 21.87 6.22F 1.43 13.99F 3.63
0.1 mM TUDCA
Simultaneous
incubation
0F 1.08 0F 0.02 0.52F 0.14 2.76F 0.75
1 h pre-
incubation
8.64F 1.64 12.26F 10.66 4.84F 0.48 18.31F12.26
4 h pre-
incubation
11.92F 6.08 25.91F 8.03 12.44F 5.72 17.44F 5.93*
Statistical significance was calculated versus acetaldehyde and ethanol,
respectively (*P < 0.05). Values are means of three independent measur-
ementsF S.D.
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acetaldehyde toxicity from 68.8% to 72.0% (P < 0.05) and
from 42.1% to 51.1% (P < 0.01) at 2.5 mM acetaldehyde.
The effect of TUDCA was significantly (P < 0.002) stron-
ger. Also EtOH-induced toxicity was significantly prevented
by UDCA and TUDCA. Better protective effects for
TUDCA than for UDCA where seen with acetaldehyde.
EtOH did not alter viability (90.4F 0.8% at 100 mM and
90.8F 2.0% at 200 mM) when ADH and CYP-2E1 was
inhibited by 4-methylpyrazole. Preincubation with bile acids
for 1 h did not much change the effects of acetaldehyde and
ethanol, whereas 4 h preincubation significantly increased
cytotoxicity (Table 3).
3.2.4. Lactate dehydrogenase leakage
LDH activity was expressed as the percentage of LDH
released into the medium of the total activity present in
hepatocytes (Table 4). Acetaldehyde induced an increase of
cytotoxicity to 4.66% at 1.5 mM and to 10.02% at 2.5 mM.
Simultaneous incubation of 1.5 mM acetaldehyde and 0.1
mM UDCA or TUDCA completely decreased LDH activity
to the control level. UDCA (0.1 mM) when simultaneously
incubated with 2.5 mM acetaldehyde reduced enzyme
activity from 10.02% to 4.15% and 0.1 mM TUDCA
completely abolished cytotoxicity. Ethanol and simulta-
neous incubation with bile acids likewise reduced cytotox-
icity. Inhibition of ethanol-oxidation abolished cytotoxicity
at 100 and 200 mM EtOH. Investigation of the efficacy of 1
and 4 h preincubation with UDCA or TUDCA followed byTable 3
Viability (%) of SK-Hep-1 cells after 24 h simultaneous incubation with
bile acids and ethanol or acetaldehyde and after 1 and 4 h preincubation
with bile acids followed by 24 h simultaneous incubation with ethanol or
acetaldehyde
Acetaldehyde
(1.5 mM)
Acetaldehyde
(2.5 mM)
EtOH
(100 mM)
EtOH
(200 mM)
a-MEM
Simultaneous
incubation
68.8F 4.0 42.1F1.2 85.5F 1.6 76.6F 4.9
0.1 mM UDCA
Simultaneous
incubation
72.0F 1.9* 51.1F 2.0** 91.7F 0.6* 86.8F 1.1*
1 h pre-
incubation
70.8F 2.1 44.2F 2.0 81.9F 4.1 77.7F 1.9
4 h pre-
incubation
63.8F 1.3* 42.1F 2.5 77.0F 3.6** 71.1F 3.3*
0.1 mM TUDCA
Simultaneous
incubation
76.2F 1.3*** 59.6F 1.9*** 93.7F 2.1* 85.7F 2.3*
1 h pre-
incubation
71.1F 3.1 44.0F 3.1 83.8F 1.8 75.9F 3.1
4 h pre-
incubation
62.7F 3.1* 42.3F 2.1 68.9F 2.5*** 66.2F 3.6**
Cells, grown in plain a-MEM medium were used as control and showed a
viability of 90.9F 1.9% (means of three independent measure-
mentsF S.D.). Statistical significance was calculated versus acetaldehyde
and ethanol, respectively. *P < 0.05; **P< 0.01; ***P< 0.002.24 h simultaneous incubation with 1.5 or 2.5 mM acetalde-
hyde, 100 or 200 mM ethanol in all experiments revealed an
increase of plasma membrane leakage compared to controls
(Table 4).
3.3. EPR investigations with intact hepatocytes
Fig. 1 shows the effect of acetaldehyde on the order
parameter s revealed with the 5-DSA spin label. Incubation
with 1.5 mM acetaldehyde reveals a drastic and significant
decrease of s to 0.64 (versus control P < 0.002), with 2.5Fig. 1. Order parameter s after 24 h simultaneous incubation of SK-Hep-1
cells with 0.1 mM bile acids and 1.5 or 2.5 mM acetaldehyde. EPR
measurements were carried out with the 5-DSA spin label (means of five
measurementsF S.D.). Statistical significance was calculated versus 2.5
mM acetaldehyde (**P< 0.01).
Fig. 2. Order parameter s after 24 h simultaneous incubation of SK-Hep-1
cells with 0.1 mM bile acids and 100 or 200 mM EtOH. EPR measurements
were carried with the 5-DSA spin label (means of five measure-
mentsF S.D.). Statistical significance was calculated versus EtOH
(***P< 0.002).
Fig. 3. The morphology of SK-Hep-1 cells exposed to 2.5 mM
acetaldehyde for 24 h was determined under the light microscope
(magnification 20 0.5).
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Under these conditions both bile acids distinctively increase
the order parameter to 0.64 for UDCA and 0.665 (versus
acetaldehyde P < 0.01) for TUDCA.
Fig. 2 shows the influence of 100 and 200 mM ethanol on
the order parameter s revealed by the 5-DSA spin label.
EtOH in both concentrations exerts no significant effect onTable 5
Interactions of bile acids with hepatocyte membranes (16-DSA) after
simultaneous and after 1 and 4 h preincubation of SK-Hep-1 cells with
UDCA or TUDCA followed by 24 h simultaneous incubation with bile
acids and ethanol or acetaldehyde
aN (G) h 1P/h 1H
Control 14.05F 0.05 0.46F 0.06
0.1 mM UDCA 14.07F 0.06 0.45F 0.07
0.1 mM TUDCA 14.13F 0.04 0.46F 0.05
2.5 mM acetaldehyde 14.22F 0.03 0.60F 0.12
200 mM EtOH 14.22F 0.15 0.61F 0.06
0.1 mM UDCA and 2.5 mM acetaldehyde
Simultaneous incubation 14.14F 0.05 0.49F 0.07
1 h preincubation 14.11F 0.05 0.53F 0.03
4 h preincubation 14.19F 0.09 0.67F 0.12#
0.1 mM TUDCA and 2.5 mM acetaldehyde
Simultaneous incubation 14.19F 0.03 0.55F 0.03
1 h preincubation 14.10F 0.05 0.49F 0.05
4 h preincubation 14.17F 0.09 0.65F 0.10#
0.1 mM UDCA and 200 mM EtOH
Simultaneous incubation 14.26F 0.03 0.87F 0.19*,#
1 h preincubation 14.29F 0.05 0.87F 0.21*,#
4 h preincubation 14.24F 0.07 0.97F 0.10*,##
0.1 mM TUDCA and 200 mM EtOH
Simultaneous incubation 14.18F 0.05 0.85F 0.04**,#
1 h preincubation 14.22F 0.10 0.93F 0.07**,#
4 h preincubation 14.21F 0.03 0.93F 0.10**,#
Statistical significance was calculated versus control (#P< 0.05; ##P< 0.01)
as well as versus ethanol and acetaldehyde, (*P< 0.05; **P < 0.01). Values
are means of five measurementsF S.D.order parameter. In contrast to UDCA, which also had no
effect, surprisingly 0.1 mM TUDCA lowers the oder param-
eter from the control level (0.712) to 0.667 (P < 0.002) at
100 mM ethanol and 0.670 (P < 0.002) at 200 mM ethanol.
Preincubation of hepatocytes for 1 and 4 h with bile acids
yielded similar effects on membrane order as obtained during
simultaneous incubation (data not shown).
Table 5 shows the influence of UDCA and TUDCA on
acetaldehyde- and ethanol-induced toxicity in the deeper,
more apolar region of the membrane (16-DSA). Both,
acetaldehyde and EtOH did not significantly alter these
domains (Table 5). UDCA or TUDCA did not significantly
change aN as well as the ratios during incubation with 2.5
mM acetaldehyde. Incubation with 200 mM EtOH and 0.1
mM UDCA or 0.1 mM TUDCA increased the ratio h 1P/
h 1H significantly indicating an increase in polarity. Pre-
incubation with bile acids yielded similar or even stronger
alterations.Fig. 4. SK-Hep-1 cells were exposed to 2.5 mM acetaldehyde for 24 h in
the presence of 0.1 mM UDCA (magnification 20 0.5).
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Cells incubated with 1.5–2.5 mM acetaldehyde appeared
morphologically rounded off (Fig. 3), whereas simultaneous
incubation with acetaldehyde and 0.1 mM UDCA or
TUDCA showed spreading and attachment to the surface
(normal finding) of the microplates (Fig. 4).
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There is no unequivocal medicamentous treatment of
alcoholic liver disease. In previous studies, steroids [14] and
UDCA or its conjugate TUDCA, have been recommended
[15]. Treatment studies in patients did not reveal convincing
effects. The toxicity of ethanol probably represents a sum-
mation of a series of adverse effects [16]. This makes it
difficult or practically impossible to study this drug in the
intact animal; in particular, the investigation of the effect of
ethanol per se without superimposed effects of other sub-
stances caused by alcohol metabolism, like acetaldehyde
and its metabolites [17]. We used a tissue culture system
which has the advantage that specific phenomena can be
studied more easily. In our in vitro study we investigated in
ADH-containing SK-Hep-1 cells whether alcohol or acetal-
dehyde in concentrations found in heavy drinkers influenced
mitochondrial metabolic activity and external hepatocyte
membranes and whether UDCA or TUDCA were able to
prevent cell damage. Whereas we could not find any AlDH
in SK-Hep-1 cells, the ADH activity was 48 mU/mg protein.
The bile acid concentrations used in our experiments were
rather high (0.01 and 0.1 mM), but lower concentrations had
no detectable effects and higher concentrations induced cell
damage (not shown). As observed by Neuman et al. [18],
the physiological dose of 0.05 mM bile acids showed
similar but in our experiments weaker effects than 0.1
mM. In contrast, they determined the lowest hepatoprotec-
tive concentration of bile acids at 0.025 mM, whereas in our
experiments even 0.01 mM UDCA or TUDCA showed
positive effects. Because of the discussions about dose
administration in hepatobiliary diseases and the promise
that high doses of UDCA may be required for therapeutic
success [19], we decided to perform the cytotoxicity experi-
ments at low (0.01 mM) and high (0.1 mM) bile acid
concentrations. For acetaldehyde and EtOH, we also used
high concentrations, since low concentrations had no de-
tectable effects, as shown by others. These investigators also
used concentrations as 80–200 mM EtOH or more to study
toxicity in hepatocytes [20–23]. Neuman et al. [18,21]
observed that culturing of HepG2 cells for 24 h with 60–
80 mM EtOH lead to 30–40% loss of viability, whereas
others [22] could not see any toxicity in their HepG2 cell
strain after incubating them for up to 3 days with 100 mM
EtOH. It seems that the cytotoxic dose of EtOH to hep-
atocytes differs between the cell strains and can probably be
accounted for by a variety of mechanisms which are due tothe metabolism of ethanol by ADH and cytochrome P450
[22]. Our findings, that the addition of the ADH- and
MEOS-inhibitor 4-methylpyrazole to the ethanol-containing
medium completely abolished the impairment caused by
ethanol-oxidation correlate with investigations of others and
demonstrate that ethanol oxidation is required for this cell
dysfunction [24]. This is also explained by Wu and Ceder-
baum [22] who made the observation that ethanol toxicity is
observed in cells which express cytochrome P4502E1 but
not in cells which do not express this cytochrome and are
therefore not able to metabolize ethanol.
Our and other data indicate that acetaldehyde provides
much stronger toxic effects than ethanol [17,24,25] and that
both UDCA and TUDCA are able to diminish some cell
damage when added to SK-Hep-1 cells simultaneously.
Since 100 AM UDCA or TUDCA did not affect ADH
activity, the beneficial effects of both bile acids must be
due to other mechanisms. It is assumed that the strong effect
of acetaldehyde is attributable to its reaction with biomole-
cules producing free radicals [26,27]. EtOH is oxidized to 1-
hydroxyethyl radical. This radical produces a state of
oxidative stress, but seems to be less toxic than the acetal-
dehyde-derived radicals [28,29]. From these data, we sup-
pose that the beneficial effects of TUDCA and UDCA at
least in part depend on the interaction with the acetaldehyde
and EtOH adducts, and not only on interactions with
biomolecules. Further investigations should elucidate this
hypothesis. It has been shown that hydrophilic bile acids
such as TUDCA counteract the inhibitory effect of ethanol
on bile secretion and vesicular exocytosis as well as the
ethanol-induced cytolytic effect in the isolated perfused rat
liver [30] and that TUDCA prevents hepatotoxicity because
of its hydrophilic properties and the ability to neutralize
toxic compounds as hydrophobic bile acids by competition
[31]. This may also be an explanation for the beneficial
effects of UDCA and TUDCA.
Interestingly, preincubation with bile acids increased
EtOH and acetaldehyde toxicity. Others have shown that
preincubation with alcohol and consecutively with bile acids
reduced toxicity in HepG2 cells [18]. But in these experi-
ments the cell strain was different from ours and incubation
time was 5-fold. During this long period of time, cells could
have recovered and become resistant to toxins.
UDCA protects against ethanol-induced mitochondrial
injury by improving ATP synthesis and preserving liver
mitochondrial morphology, which may contribute to the
decrease in fat accumulation [32]. Our biochemical inves-
tigations revealed that UDCA obviously better protects
mitochondrial function, while TUDC better prevents mem-
brane damage. This was shown by the WST-1 test with both
reagents, EtOH and acetaldehyde. In investigations not only
testing for cell function but also for membrane structure and
integrity, TUDCA was superior to UDCA. This, e.g., was
the case investigating the GSH release and cell viability. The
antioxidant GSH, besides being distributed in the cyto-
plasm, is also located in liver cell mitochondria. As shown
K. Henzel et al. / Biochimica et Biophysica Acta 1644 (2004) 37–4544previously, UDCA and TUDCA protect hepatocyte mito-
chondria through modulation of mitochondrial membrane
fluidity and subsequent normalization of GSH levels
[33,34]. TUDCA selectively increased GSH levels in the
mitochondria of ethanol-fed rats but not the cytosolic GSH
and preserved membrane fluidity of mitochondria and
mitoplasts, whereas without TUDCA, the order parameter
increased [33]. Others found that HepG2 cells exposed for
24 h to 80 mM EtOH in the presence of 0.05 mM UDCA or
TUDCA increased GSH levels in mitochondria as well as in
the cytosol [5]. This is supported by recent investigations
[35] that UDCA specifically enhanced methionine adeno-
syltransferase activity and hepatic GSH levels.
Since in our experiments GSH was measured in the
supernatant, we assessed both the cytoplasmic and the
mitochondrial GSH fraction which had passed through the
outer cell membrane. Therefore, GSH also informs about
cell viability on which we focused as an universal param-
eter. The cell viability test secondarily depends on mem-
brane integrity. Trypan blue only enters the hepatocyte
through a leaky membrane of an injured cell. But since
there is a strong correlation between dye uptake and cell
death, the trypan blue test not only informs us on hepatocyte
membranes but also on viability. Even early stages of cell
death can be recorded. The LDH test does not report on cell
function but predominantly on the degree of membrane
damage. Accordingly, in the above-mentioned tests,
TUDCA protected cell membranes better than UDCA,
which may be due to the different cellular uptake mecha-
nisms for UDCA and TUDCA and the different concen-
trations in biomembranes and cell organelles [36,37].
Therefore, the higher intracellular UDCA concentration
could react with the deeper membrane domains and intra-
cellular structures.
Another explanation for the different actions of UDCA
and TUDCA is provided by our EPR investigations which are
in accordance with the biochemical investigations. Both bile
acids were found not to interfere with the low polarity in the
membrane’s hydrophobic, deeper domain (spin label 16-
DSA). Both, ethanol and acetaldehyde, however, increased
polarity. Simultaneous incubation of acetaldehyde and bile
acids did not significantly increase polarity in this deeper
domain, but simultaneous incubation of ethanol and bile
acids did. These findings suggest that EtOH interacts with
the more apolar domain of the membrane and is influenced by
bile acids, while the effect of acetaldehyde is not.
In the polar, more superficial part of the membrane (spin
label 5-DSA), there was a maximal decrease of order
observed in the presence of acetaldehyde. Evidently, polar
acetaldehyde severely and instantly damages the superficial
polar domain of the cell membrane surface. Consequently,
the more polarly anchored TUDCA is most effective in
reducing the damage, shown by the increase of the order
parameter. Ethanol only in the presence of the more polar
TUDCA decreased the order parameter of 5-DSA, whereas
the combination of EtOH with the less polar UDCA iswithout effect. This result fits very well with the observation
that in most experiments UDCA proved superior in restitu-
tion of ethanol-induced damage. Like in the biochemical
tests, also in the EPR investigations preincubation with bile
acids for 1 and 4 h before ethanol increased polarity or
membrane damage.
To summarize, ethanol appears to induce much more
damage at the apolar membrane site than at the polar
membrane surface. Acetaldehyde, in contrast, mostly dam-
ages the membrane surface due to its more polar character.
The acetaldehyde-induced superficial membrane damage is
counteracted by the polarly anchored TUDCA, while
UDCA better preserves mitochondrial function. The alter-
ations in cell integrity during alcohol metabolism seem
dependent on acetaldehyde rather than ethanol [23].
Taking into account our in vitro investigations and the
experience of others, we believe bile acid therapy in patients
with alcoholic liver disease appears rather dubious: benefi-
cial effects of bile acids were only seen with rather high and
unphysiological concentrations; preincubation of hepato-
cytes with bile acids significantly deteriorated cell damage
caused by ethanol and acetaldehyde while simultaneous
incubation reduced cell damage, and in contrast to our
results, others had positive as well as negative effects
[35]. Our preincubation studies with bile acids suggest that
in sober alcoholics, it is likely that the bile acids may in fact
be toxic to the liver.References
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